Showing results (91-100 of 4,006) with videos related to
Sort By:
Pageof 401
Psychiatry and Clinical Neurosciences|February 1, 1997
Significance of monitoring plasma levels of amitriptyline, and its hydroxylated and desmethylated metabolites in prediction of the clinical outcome of depressive stateK Shimoda, S Yasuda, S Morita, et al.Therapeutic Drug Monitoring|August 15, 2000
CYP2D6*10 alleles are not the determinant of the plasma haloperidol concentrations in Asian patientsK Shimoda, S Morita, A Yokono, et al.Journal of Clinical Psychopharmacology|June 1, 1995
Interindividual variations of desmethylation and hydroxylation of amitriptyline in a Japanese psychiatric populationK Shimoda, T Noguchi, S Morita, et al.Pharmacogenetics|October 1, 1991
Identification of a new variant CYP2D6 allele lacking the codon encoding Lys-281: possible association with the poor metabolizer phenotypeR Tyndale, T Aoyama, F Broly, et al.European Journal of Clinical Pharmacology|January 1, 1995
Variable activation of lovastatin by hydrolytic enzymes in human plasma and liver. 4B K Tang, W KalowClinical Pharmacology and Therapeutics|November 1, 1991
Use of caffeine metabolite ratios to explore CYP1A2 and xanthine oxidase activitiesW Kalow, B K TangClinical Pharmacology and Therapeutics|July 1, 1993
Thiopurine S-methyltransferase activity in a Chinese populationE J Lee, W KalowClinical Pharmacology and Therapeutics|January 1, 1991
Caffeine as a metabolic probe: exploration of the enzyme-inducing effect of cigarette smokingW Kalow, B K TangBiochemistry|September 5, 1989
cDNA cloning and sequence and cDNA-directed expression of human P450 IIB1: identification of a normal and two variant cDNAs derived from the CYP2B locus on chromosome 19 and differential expression of the IIB mRNAs in human liverS Yamano, P T Nhamburo, T Aoyama, et al.Therapeutic Drug Monitoring|June 12, 1999
Lower plasma levels of haloperidol in smoking than in nonsmoking schizophrenic patientsK Shimoda, T Someya, S Morita, et al.Pageof 401